|
Identification of leptomeningeal metastasis-specific exosomal miRNA signature in cerebrospinal fluid of non-small-cell lung cancer patients. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Geneseeq Technology Inc. |
Leadership - Geneseeq Technology Inc. |
|
|
Employment - Geneseeq Technology Inc. |
|
|
Employment - Geneseeq Technology Inc. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Geneseeq Technology Inc. |
|
|
No Relationships to Disclose |
|
|
Employment - Geneseeq Technology Inc. |
|
|
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche; Sanofi |
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Roche |
Research Funding - Boehringer Ingelheim (Inst); Roche (Inst) |